Gene Therapy of Arthritis with Tcr Isolated from the Inflamed Paw.
From: Department of Allergy and Rheumatology, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. kfujio-tky@umin.ac.jp
Journal of immunology (Baltimore, Md. : 1950)
- Publish Date: Dec 2006
- ISSN: 0022-1767
- Volume: 177
- Issue: 11
- Pages: 8140-7
- Medium: Print
- Language: English
- Citation (JAMA): Fujio Keishi, Okamoto Akiko, Araki Yasuto, et al. Gene Therapy of Arthritis with Tcr Isolated from the Inflamed Paw.. J. Immunol. Dec 2006;177:8140-7
Abstract
In recent years, the treatment of autoimmune diseases has been significantly advanced by the use of biological agents. However, some biologics are accompanied with severe side effects, including tuberculosis and other types of infection. There is thus a critical need for nonsystemic and lesion-specific methods of delivering these therapeutic agents. We attempted to treat a mouse model of arthritis by using T cells that expressed a regulatory molecule and were specifically directed to the inflamed paw. To this end, we first identified the TCR alphabeta genes accumulating in the inflamed paw of mice with collagen-induced arthritis (CIA) by a combination of single-strand chain polymorphism analysis of TCR and single-cell sorting. We identified an expanded clone B47 which is autoreactive but is not specific to type II collagen. In vivo, TCR genes from B47-transduced T cells accumulated in the inflamed paw. Injection of cells cotransduced with the B47 and soluble TNFRIg genes resulted in a significant suppression of CIA. The suppression was correlated with the amount of TNFRIg transcripts in the hind paw, not with the serum concentrations of TNFRIg. Moreover, T cells cotransduced with the B47 and intracellular Foxp3 genes significantly suppressed CIA with reductions in TNF-alpha, IL-17A, and IL-1beta expression and bone destruction. T cells cotransduced with B47 and Foxp3 genes also suppressed the progression of established CIA. Therefore, immunosuppressive therapy with autoreactive TCR is a promising therapeutic strategy for arthritis whether the TCRs are used to deliver either soluble or intracellular suppressive molecules.
Mesh Headings (Keywords): Adoptive Transfer, Amino Acid Sequence, Animals, Arthritis, Experimental, Autoantibodies, Autoantigens, Cell Proliferation, Flow Cytometry, Forelimb, Forkhead Transcription Factors, Gene Therapy, Hindlimb, Inflammation, Mice, Mice, Inbred DBA, Molecular Sequence Data, Polymorphism, Single Nucleotide, Receptors, Antigen, T-Cell, Receptors, Tumor Necrosis Factor, Reverse Transcriptase Polymerase Chain Reaction, T-Lymphocytes, Transduction, Genetic
Check for Full Text / PubMed Unique Identifier (PMID): 17114489
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.